Evorel Conti Patches

In stock

Price range: £35.00 through £79.98

Evorel Conti is a continuous combined HRT patch containing estradiol and norethisterone acetate. It provides both hormones throughout treatment and is changed twice weekly. Suitability depends on your menopause stage and medical history.

Pack size: 1, 2 or 3 boxes of 8 patches.
Supply length: 4, 8 or 12 weeks respectively, at two patch changes a week.

Prescription treatment. A clinical assessment is required before supply. Select only the preparation and strength agreed with your prescriber.

Start Assessment

Subject to approval by our clinical team

Free delivery
On orders over £40

Discreet packaging
Plain, unbranded outer

GPhC-registered pharmacy
UK-regulated dispensing

Fast UK dispatch
Once approved

Evorel Conti Patches: Key Info

Evorel Conti is a continuous combined HRT patch containing estradiol and norethisterone acetate. It provides both hormones throughout treatment and is changed twice weekly. Suitability depends on your menopause stage and medical history.

Continuous combined HRT

Evorel Conti supplies oestrogen and a progestogen in each patch. It is used after menopause when a continuous combined regimen is appropriate. The progestogen helps protect the womb lining from the effects of oestrogen.

It is not the same as oestrogen-only Evorel or sequential Evorel Sequi. Tell the prescriber when your last period occurred and which HRT you currently use.

Dose and available pack sizes

Each patch releases 50 micrograms of estradiol and 170 micrograms of norethisterone acetate per 24 hours. Select 1 × 8, 2 × 8 or 3 × 8 patches to see the private price.

At the usual twice-weekly schedule, eight patches cover four weeks. Your actual regimen and repeat supply are confirmed by the clinician. The photograph is an example carton; multi-carton orders contain the selected total quantity.

Using Evorel Conti

Apply patches to the trunk below the waist and rotate the site. Keep to your two change days each week. A patch can usually remain on during bathing or showering; follow the leaflet if it comes off.

The continuous regimen is intended to avoid a scheduled monthly withdrawal bleed, but spotting may happen. Unexpected or persistent bleeding needs assessment.

Choosing between HRT preparations

Evorel Sequi uses different patches in two phases, while Evorel supplies oestrogen alone. A patch is not automatically more suitable because it avoids tablets; individual benefits and risks still need review.

Your menopause assessment

Use our menopause consultation to discuss symptoms, existing HRT and the treatment you would prefer. A clinician reviews suitability before prescribing. Choosing a product does not guarantee supply. Tell the team about unexpected bleeding, your last period, any hysterectomy and all medicines you use.

HRT is not contraception. If pregnancy is still possible, ask about appropriate contraception. Do not change between HRT preparations or add hormones without advice.

Information checked on 28 October 2026 against Evorel Conti patient leaflet, Evorel Conti prescribing information and NHS HRT guidance. Always read the leaflet supplied with your medicine.

Directions

How to use Evorel Conti

Wear one patch at a time and change it twice weekly, usually after three and four days, without a break between packs unless told otherwise. Apply to clean, dry, unbroken skin below the waist. Avoid the breasts and do not use creams underneath.

If a patch falls off, follow the replacement instructions and keep your usual change days. Ask the pharmacy about missed changes or starting after another HRT regimen.

Ingredients

Evorel Conti ingredients

Each patch contains estradiol hemihydrate and norethisterone acetate. The nominal daily release is 50 micrograms estradiol plus 170 micrograms norethisterone acetate.

The adhesive matrix includes acrylate-vinylacetate copolymer and guar gum. Read the leaflet for the full list and tell the pharmacy about adhesive reactions.

Side Effects

Possible side effects

Application-site reactions, headache, breast tenderness, nausea and bleeding or spotting can occur. Ask for advice if these persist or affect daily life.

Report unexplained or persistent vaginal bleeding and breast changes. Attend recommended screening and regular HRT reviews. Individual benefits and risks depend on the treatment, dose, duration and your health history.

Call 999 for sudden chest pain, breathlessness, signs of a stroke or a severe allergic reaction. Seek urgent medical advice for a painful, swollen leg. Stop HRT and seek prompt advice for jaundice, a new migraine-type headache or pregnancy.

Warnings

Before using Evorel Conti

Do not use if a listed contraindication applies, including breast cancer, an oestrogen-dependent cancer, unexplained vaginal bleeding, untreated endometrial hyperplasia, previous or current blood clots, a known clotting disorder, recent arterial clotting disease, active liver disease or porphyria. This is not a complete list; check the leaflet and discuss your history with the prescriber.

A clinician must check whether continuous combined HRT is appropriate for your stage of menopause. Do not use in pregnancy or breastfeeding. Report any new health condition, medicine or planned operation before continuing treatment.

Does Evorel Conti contain progesterone?

It contains norethisterone acetate, a progestogen, alongside estradiol. It does not contain micronised progesterone.

What pack sizes are listed?

Choose one, two or three eight-patch cartons: eight, 16 or 24 patches in total.

How long does one eight-patch carton last?

At the usual twice-weekly change schedule, it covers four weeks. Follow your prescribed regimen.

Will I have a monthly period with Conti?

It is a continuous combined regimen without a planned monthly withdrawal bleed. Spotting can happen; persistent or unexpected bleeding needs assessment.

Can I swap Evorel Sequi for Conti?

Do not switch without advice. The hormone schedule differs, and suitability depends on your history and stage of menopause.

1
Yes